| 2020-12-03 | Sale | Y-mAbs Therapeutics, Inc. YMAB | Chief Executive Officer | 18,532 0.0464% | $50.98 | $944,754 | -35.1% | |
| 2020-12-02 | Sale | Y-mAbs Therapeutics, Inc. YMAB | Chief Executive Officer | 81,468 0.1023% | $25.63 | $2.09M | -35.21% | |
| 2020-05-14 | Sale | Y-mAbs Therapeutics, Inc. YMAB | Chief Executive Officer | 278,308 0.6952% | $36.02 | $10.03M | +13.11% | |
| 2020-05-13 | Sale | Y-mAbs Therapeutics, Inc. YMAB | Chief Executive Officer | 121,692 0.3036% | $37.75 | $4.59M | +7.79% | |
| 2020-03-17 | Y-mAbs Therapeutics, Inc. YMAB | Chief Executive Officer | 3,800 0.0091% | $17.22 | $65,423 | +125.97% | ||
| 2018-09-25 | Y-mAbs Therapeutics, Inc. YMAB | Chief Executive Officer | 31,250 0.0724% | $16.00 | $500,000 | -9.89% |